MannKind saw decent growth from its two core products in Q2 and just signed a new non-dilutive financing agreement with ...

The company submitted its lead inhaled insulin product for expanded FDA approval and secured $500 million in funding, it said ...

(HealthDay News) — Intranasal administration of [ 68 Ga]Ga-NOTA-insulin is safe and delivers insulin to multiple brain regions, according to a study published online July 23 in Alzheimer’s & Dementia: ...

MannKind Corporation (NASDAQ:MNKD) presented inhaled insulin therapy at the American Diabetes Association’s 85th Scientific Sessions in Chicago, which was held from June 20 to June 23, 2025.

Ultra-rapid insulins are used to manage type 1 and type 2 diabetes. Learn about the different types, their effectiveness, and how they can provide mealtime flexibility.

The global health landscape is evolving with Brazil battling bird flu-related trade restrictions, Nestle USA eliminating synthetic food colors by 2026, and Novo Nordisk launching a weight-loss drug in ...

Recent advancements in inhaled insulin for type 1 diabetes and once-weekly insulin for type 2 diabetes present promising alternatives to injections. Additionally, genetically engineered skin grafts ...

(Reuters) -Children with diabetes who inhaled their mealtime doses of insulin did just as well as those who injected insulin under the skin, researchers reported at the American Diabetes Association ...